Accueil Healthcare Molecular Cytogenetics Market – Learn The Investment Strategy Of Market Players To Increase Business Growth

Molecular Cytogenetics Market – Learn The Investment Strategy Of Market Players To Increase Business Growth

Molecular Cytogenetics Market

Global molecular cytogenetics market is forecasted to attain revenue of $3.3 billion by 2023. The market is mainly driven by growing implementation of pharmacogenomics in personalized disease management and drug development, rising cancer cases, advancements in cytogenetic techniques, and rise in genetic-based prediction of chromosomal abnormalities.

Explore report sample at:

During the forecast period, the molecular cytogenetics market is expected to witness fastest growth in personalized medicine application, at a CAGR of 10.1%. This growth is attributable to rise in demand for precision medicine coupled with high investments in research and development.

Based on end user, the molecular cytogenetics market has been classified into clinical and research laboratories, academic research institutes, hospitals and pathology laboratories and pharmaceutical and biotechnology companies. Among these, clinical and research laboratories held the largest share as an end-user category during the historical period in this market and accounted for a 33.4 % share in 2017.

Browse report at:

Globally, key players in the molecular cytogenetics industry are developing new instruments and tests for the molecular diagnosing, genetic screening and other tests. For instance, in July 2017, Quest Diagnostics announced the launch of a genetic screening service, QHerit. The service is for the detection of genetic risk associated to offspring through passing of heritable disorders. The QHerit Pan-Ethnic Expanded Carrier Screen is a panel of tests for the 22 heritable diseases cited under new screening guidelines issued in March 2017 by the American College of Gynecology (ACOG).

Some of the other key players operating in the molecular cytogenetics industry include Abbott Laboratories, Danaher Corporation, Bio-Rad Laboratories Inc., F. Hoffmann La-Roche AG, PerkinElmer Inc., Illumina Inc, Agilent Technologies Inc and NeoGenomics Inc.

Source: P&S Intelligence

Charger d'autres articles liés
Charger d'autres écrits par healthcarenewswire
Charger d'autres écrits dans Healthcare

Laisser un commentaire

Consulter aussi

Molecular Biology Kits and Enzymes Market Size, Share, Key Players Analysis and Forecast by 2022

The molecular biology kits and reagents and enzymes market is growing due to increasing ge…